Current Challenges in Head and Neck Cancer Management

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Jan 21

PMID 35053520

Authors

Anna Starzynska

Bartosz Kamil Sobocki

Daniela Alterio

Affiliations

Soon will be listed here.

Abstract

More than 500,000 new cases of head and neck cancer (HNC) occur each year worldwide [...].

Citing Articles

Medical Honey in Head and Neck Cancer.

Badders J, Coblens O, Ranasinghe V, Shabani S Cureus. 2024; 16(1):e52822.

PMID: 38406013 PMC: 10884620. DOI: 10.7759/cureus.52822.

Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study.

Kadela-Tomanek M, Krzykawski K, Halama A, Kubina R Molecules. 2023; 28(18).

PMID: 37764419 PMC: 10535307. DOI: 10.3390/molecules28186644.

RNA-Based Liquid Biopsy in Head and Neck Cancer.

Kabzinski J, Kucharska-Lusina A, Majsterek I Cells. 2023; 12(14).

PMID: 37508579 PMC: 10377854. DOI: 10.3390/cells12141916.

Kaempferol and Fisetin-Related Signaling Pathways Induce Apoptosis in Head and Neck Cancer Cells.

Kubina R, Krzykawski K, Dziedzic A, Kabala-Dzik A Cells. 2023; 12(12).

PMID: 37371038 PMC: 10297294. DOI: 10.3390/cells12121568.

Capecitabine-A "Permanent Mission" in Head and Neck Cancers "War Council"?.

Mirestean C, Iancu R, Iancu D J Clin Med. 2022; 11(19).

PMID: 36233450 PMC: 9573684. DOI: 10.3390/jcm11195582.

References

Kitamura N, Sento S, Yoshizawa Y, Sasabe E, Kudo Y, Yamamoto T . Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci. 2021; 22(1). PMC: 7795499. DOI: 10.3390/ijms22010240. View

Moratin J, Horn D, Metzger K, Ristow O, Flechtenmacher C, Engel M . Squamous cell carcinoma of the mandible - Patterns of metastasis and disease recurrence in dependence of localization and therapy. J Craniomaxillofac Surg. 2020; 48(12):1158-1163. DOI: 10.1016/j.jcms.2020.10.006. View

Payne K, Brooks J, Spruce R, Batis N, Taylor G, Nankivell P . Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects. Cancers (Basel). 2019; 11(8). PMC: 6721520. DOI: 10.3390/cancers11081115. View

Cohen E, Bell R, Bifulco C, Burtness B, Gillison M, Harrington K . The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer. 2019; 7(1):184. PMC: 6632213. DOI: 10.1186/s40425-019-0662-5. View

Kong L, Birkeland A . Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges. Cancers (Basel). 2021; 13(8). PMC: 8070729. DOI: 10.3390/cancers13081874. View

Hofmann L, Ludwig S, Vahl J, Brunner C, Hoffmann T, Theodoraki M . The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer. Int J Mol Sci. 2020; 21(11). PMC: 7312915. DOI: 10.3390/ijms21114072. View

Kawakita D, Matsuo K . Alcohol and head and neck cancer. Cancer Metastasis Rev. 2017; 36(3):425-434. DOI: 10.1007/s10555-017-9690-0. View

Fanetti G, Alterio D, Marvaso G, Gandini S, Rojas D, Gobitti C . Prognostic significance of neutrophil-to-lymphocyte ratio in HPV status era for oropharyngeal cancer. Oral Dis. 2020; 26(7):1384-1392. DOI: 10.1111/odi.13366. View

Scott J, Sedor G, Ellsworth P, Scarborough J, Ahmed K, Oliver D . Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis. Lancet Oncol. 2021; 22(9):1221-1229. DOI: 10.1016/S1470-2045(21)00347-8. View

10.

Starzynska A, Sobocki B, Sejda A, Sakowicz-Burkiewicz M, Szot O, Jereczek-Fossa B . ZNF-281 as the Potential Diagnostic Marker of Oral Squamous Cell Carcinoma. Cancers (Basel). 2021; 13(11). PMC: 8197962. DOI: 10.3390/cancers13112661. View

11.

Carnielli C, Macedo C, De Rossi T, Granato D, Rivera C, Domingues R . Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nat Commun. 2018; 9(1):3598. PMC: 6125363. DOI: 10.1038/s41467-018-05696-2. View

12.

Schmidt H, Kulasinghe A, Kenny L, Punyadeera C . The development of a liquid biopsy for head and neck cancers. Oral Oncol. 2016; 61:8-11. DOI: 10.1016/j.oraloncology.2016.07.014. View

13.

Makitie A, Almangush A, Youssef O, Metsala M, Silen S, Nixon I . Exhaled breath analysis in the diagnosis of head and neck cancer. Head Neck. 2019; 42(4):787-793. DOI: 10.1002/hed.26043. View

14.

Karam S, Raben D . Radioimmunotherapy for the treatment of head and neck cancer. Lancet Oncol. 2019; 20(8):e404-e416. DOI: 10.1016/S1470-2045(19)30306-7. View

15.

Muzaffar J, Bari S, Kirtane K, Chung C . Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2021; 13(2). PMC: 7831487. DOI: 10.3390/cancers13020338. View

16.

Marcu L, Marcu D . Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy. J Pers Med. 2021; 11(11). PMC: 8625829. DOI: 10.3390/jpm11111094. View

17.

Cohen N, Fedewa S, Chen A . Epidemiology and Demographics of the Head and Neck Cancer Population. Oral Maxillofac Surg Clin North Am. 2018; 30(4):381-395. DOI: 10.1016/j.coms.2018.06.001. View

18.

Biau J, Bourhis J . Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?. Curr Opin Oncol. 2020; 32(3):196-202. DOI: 10.1097/CCO.0000000000000628. View

19.

Bellairs J, Hasina R, Agrawal N . Tumor DNA: an emerging biomarker in head and neck cancer. Cancer Metastasis Rev. 2017; 36(3):515-523. PMC: 5839661. DOI: 10.1007/s10555-017-9685-x. View

20.

Hasnat S, Hujanen R, Nwaru B, Salo T, Salem A . The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2020; 21(19). PMC: 7582583. DOI: 10.3390/ijms21197255. View